Ignite Creation Date:
2025-12-24 @ 12:50 PM
Ignite Modification Date:
2026-01-27 @ 2:06 PM
Study NCT ID:
NCT00566761
Status:
TERMINATED
Last Update Posted:
2024-05-30
First Post:
2007-11-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO
Sponsor:
Asociación para Evitar la Ceguera en México
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-06
Start Date Type:
ACTUAL
Primary Completion Date:
2007-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-11-30
First Submit QC Date:
None
Study First Post Date:
2007-12-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-29
Last Update Post Date:
2024-05-30
Last Update Post Date Type:
ACTUAL